Latest Insider Transactions at Walgreens Boots Alliance, Inc. (WBA)
This section provides a real-time view of insider transactions for Walgreens Boots Alliance, Inc. (WBA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Walgreens Boots Alliance, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Walgreens Boots Alliance, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 01
2022
|
Danielle Gray EVP and Global CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,229
-2.66%
|
$44,244
$36.26 P/Share
|
Nov 01
2022
|
Danielle Gray EVP and Global CLO |
BUY
Grant, award, or other acquisition
|
Direct |
33,644
+42.15%
|
-
|
Nov 01
2022
|
Holly May EVP, Global Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
957
-2.42%
|
$34,452
$36.26 P/Share
|
Nov 01
2022
|
Holly May EVP, Global Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,762
+42.93%
|
-
|
Nov 01
2022
|
Steven J Shulman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,136
+14.13%
|
-
|
Nov 01
2022
|
Kevin M. Ban EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
649
-1.15%
|
$23,364
$36.26 P/Share
|
Nov 01
2022
|
Kevin M. Ban EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,292
+45.19%
|
-
|
Nov 01
2022
|
John Patrick Driscoll EVP, Pres. U.S. Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
51,760
+50.0%
|
-
|
Nov 01
2022
|
Tracey D Brown EVP, Pres., Walgreens Retail |
SELL
Payment of exercise price or tax liability
|
Direct |
956
-2.52%
|
$34,416
$36.26 P/Share
|
Nov 01
2022
|
Tracey D Brown EVP, Pres., Walgreens Retail |
BUY
Grant, award, or other acquisition
|
Direct |
28,468
+42.83%
|
-
|
Nov 01
2022
|
Henry Lee Cooper EVP, Pres. Walgreens Pharmacy |
BUY
Grant, award, or other acquisition
|
Direct |
32,544
+49.99%
|
-
|
Nov 01
2022
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,515
+19.98%
|
-
|
Nov 01
2022
|
Ornella Barra Chief Operating Officer, Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
3,285
-1.01%
|
$118,260
$36.26 P/Share
|
Nov 01
2022
|
Ornella Barra Chief Operating Officer, Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
58,230
+15.23%
|
-
|
Nov 01
2022
|
Stefano Pessina Executive Chairman of Board |
SELL
Payment of exercise price or tax liability
|
Direct |
4,509
-0.54%
|
$162,324
$36.26 P/Share
|
Oct 26
2022
|
Manmohan Mahajan EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,311
-9.6%
|
$45,885
$35.51 P/Share
|
Oct 26
2022
|
Manmohan Mahajan EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
4,472
+24.67%
|
-
|
Oct 26
2022
|
James Kehoe EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,752
-10.91%
|
$866,320
$35.51 P/Share
|
Oct 26
2022
|
James Kehoe EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
57,498
+20.22%
|
-
|
Oct 26
2022
|
Ornella Barra Chief Operating Officer, Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
8,390
-3.06%
|
$293,650
$35.51 P/Share
|
Oct 26
2022
|
Ornella Barra Chief Operating Officer, Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
57,498
+17.33%
|
-
|
Oct 26
2022
|
Stefano Pessina Executive Chairman of Board |
BUY
Grant, award, or other acquisition
|
Direct |
371,281
+19.67%
|
-
|
Oct 26
2022
|
Stefano Pessina Executive Chairman of Board |
SELL
Sale (or disposition) back to the issuer
|
Direct |
33,547
-4.8%
|
$1,174,145
$35.51 P/Share
|
Sep 01
2022
|
John T Standley EVP and President, Walgreen Co |
SELL
Payment of exercise price or tax liability
|
Direct |
4,331
-4.63%
|
$151,585
$35.26 P/Share
|
May 01
2022
|
James Kehoe EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,733
-3.3%
|
$240,786
$42.4 P/Share
|
Apr 27
2022
|
James Kehoe EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
18,832
+9.79%
|
-
|
Mar 15
2022
|
Rosalind G Brewer CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
25,304
-10.05%
|
$1,214,592
$48.17 P/Share
|
Nov 19
2021
|
Nancy M Schlichting Director |
SELL
Open market or private sale
|
Direct |
2,725
-14.12%
|
$128,075
$47.16 P/Share
|
Nov 01
2021
|
Stefano Pessina Executive Chairman of Board |
SELL
Payment of exercise price or tax liability
|
Direct |
4,979
-1.02%
|
$234,013
$47.32 P/Share
|
Nov 01
2021
|
Jose E Almeida Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,226
+19.38%
|
-
|
Nov 01
2021
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,226
+17.97%
|
-
|
Nov 01
2021
|
Ornella Barra Chief Operating Officer, Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
2,420
-1.12%
|
$113,740
$47.32 P/Share
|
Nov 01
2021
|
Ornella Barra Chief Operating Officer, Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
23,462
+9.76%
|
-
|
Nov 01
2021
|
James Kehoe EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,705
-2.43%
|
$362,135
$47.32 P/Share
|
Nov 01
2021
|
James Kehoe EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
23,462
+12.77%
|
-
|
Nov 01
2021
|
Holly May EVP, Global Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,385
+50.0%
|
-
|
Nov 01
2021
|
Danielle Gray EVP and Global CLO |
BUY
Grant, award, or other acquisition
|
Direct |
11,992
+50.0%
|
-
|
Nov 01
2021
|
Manmohan Mahajan EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
397
-2.15%
|
$18,659
$47.32 P/Share
|
Nov 01
2021
|
Manmohan Mahajan EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,910
+29.57%
|
-
|
Nov 01
2021
|
Rosalind G Brewer CEO |
BUY
Grant, award, or other acquisition
|
Direct |
59,958
+19.54%
|
-
|
Nov 01
2021
|
John T Standley EVP and President, Walgreen Co |
SELL
Payment of exercise price or tax liability
|
Direct |
3,792
-4.02%
|
$178,224
$47.32 P/Share
|
Nov 01
2021
|
John T Standley EVP and President, Walgreen Co |
BUY
Grant, award, or other acquisition
|
Direct |
20,855
+18.1%
|
-
|
Nov 01
2021
|
James A Skinner Exec. Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
51,794
-7.31%
|
$2,434,318
$47.32 P/Share
|
Oct 19
2021
|
Ornella Barra Chief Operating Officer, Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
7,917
-3.93%
|
$380,016
$48.01 P/Share
|
Oct 19
2021
|
Ornella Barra Chief Operating Officer, Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
46,316
+18.69%
|
-
|
Oct 19
2021
|
Stefano Pessina Executive Chairman of Board |
SELL
Payment of exercise price or tax liability
|
Direct |
33,276
-6.35%
|
$1,597,248
$48.01 P/Share
|
Oct 19
2021
|
Stefano Pessina Executive Chairman of Board |
BUY
Grant, award, or other acquisition
|
Direct |
164,681
+23.92%
|
-
|
Oct 19
2021
|
James Kehoe EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,959
-10.45%
|
$766,032
$48.01 P/Share
|
Oct 19
2021
|
James Kehoe EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
36,024
+19.08%
|
-
|
Oct 19
2021
|
James A Skinner Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
197,531
+21.8%
|
-
|